🇧🇷 H5G1.1 in Brazil

H5G1.1 (ECULIZUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

H5G1.1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Brazil

Frequently asked questions

Is H5G1.1 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for H5G1.1 in Brazil?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.